MX2021011401A - Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion. - Google Patents

Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion.

Info

Publication number
MX2021011401A
MX2021011401A MX2021011401A MX2021011401A MX2021011401A MX 2021011401 A MX2021011401 A MX 2021011401A MX 2021011401 A MX2021011401 A MX 2021011401A MX 2021011401 A MX2021011401 A MX 2021011401A MX 2021011401 A MX2021011401 A MX 2021011401A
Authority
MX
Mexico
Prior art keywords
fosfomycin
pharmaceutically acceptable
acceptable salt
quantification
impurities
Prior art date
Application number
MX2021011401A
Other languages
English (en)
Inventor
Robert Divasto
Marta Mariño
Original Assignee
Laboratorios Ern S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Ern S A filed Critical Laboratorios Ern S A
Publication of MX2021011401A publication Critical patent/MX2021011401A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/84—Preparation of the fraction to be distributed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • B01D15/305—Hydrophilic interaction chromatography [HILIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/64—Electrical detectors
    • G01N2030/645—Electrical detectors electrical conductivity detectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/84—Preparation of the fraction to be distributed
    • G01N2030/8447—Nebulising, aerosol formation or ionisation
    • G01N2030/8452—Generation of electrically charged aerosols or ions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/64—Electrical detectors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a un método para la detección y cuantificación de fosfomicina y de sus impurezas y/o productos de degradación en muestras de fosfomicina o una sal de la misma farmacéuticamente aceptable o en composiciones farmacéuticas que comprenden fosfomicina o una sal de la misma farmacéuticamente aceptable. La presente invención además se refiere a un proceso de fabricación de fosfomicina o una sal de la misma farmacéuticamente aceptable que tiene un grado de pureza especificada, así como a la fosfomicina o una sal de la misma farmacéuticamente aceptable obtenidas. La presente invención además se refiere a un proceso de fabricación de una composición farmacéutica que comprende fosfomicina o una sal de la misma farmacéuticamente aceptable y al menos un excipiente farmacéuticamente aceptable que tiene un grado de pureza especificada, así como a la composición farmacéutica obtenida.
MX2021011401A 2019-03-21 2020-03-10 Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion. MX2021011401A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201930256A ES2784076B2 (es) 2019-03-21 2019-03-21 Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion
PCT/EP2020/056327 WO2020187644A1 (en) 2019-03-21 2020-03-10 Method for the detection and quantification of fosmomycin, impurities and degradation products thereof

Publications (1)

Publication Number Publication Date
MX2021011401A true MX2021011401A (es) 2022-02-11

Family

ID=69810825

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011401A MX2021011401A (es) 2019-03-21 2020-03-10 Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion.

Country Status (5)

Country Link
US (1) US20220146470A1 (es)
CA (1) CA3132408A1 (es)
ES (2) ES2784076B2 (es)
MX (1) MX2021011401A (es)
WO (1) WO2020187644A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102353452B1 (ko) * 2020-12-23 2022-01-21 한국과학기술원 에어로졸화된 비말 검출장치
CN113406259A (zh) * 2021-05-28 2021-09-17 海南海灵化学制药有限公司 一种拉氧头孢钠杂质的检测方法
CN115097051B (zh) * 2022-07-27 2023-03-24 广州艾奇西新药研究有限公司 一种使用高效液相色谱分离检测磷霉素钠及其制剂中有关物质的方法
CN115798573B (zh) * 2023-02-02 2023-05-09 武汉宏韧生物医药股份有限公司 一种药物成分分析方法及装置
CN117213385A (zh) * 2023-10-10 2023-12-12 江苏神力特生物科技股份有限公司 一种检测和定量牛樟芝固态发酵物中的安卓奎诺尔的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9441053B2 (en) * 2013-07-11 2016-09-13 Scinopharm Taiwan, Ltd. Analytical method for detecting sulfated oligosaccharides
GB201417341D0 (en) * 2014-10-01 2014-11-12 Isis Innovation Chromatography

Also Published As

Publication number Publication date
US20220146470A1 (en) 2022-05-12
ES2784076A1 (es) 2020-09-21
ES2872674R1 (es) 2022-07-21
ES2872674B2 (es) 2023-06-29
ES2784076B2 (es) 2021-04-12
CA3132408A1 (en) 2020-09-24
ES2872674A2 (es) 2021-11-02
WO2020187644A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
MX2021011401A (es) Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion.
AR125321A2 (es) Compuesto cristalino, método de preparación y composición que lo comprende
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
SA517390509B1 (ar) مركب مشتق ثلاثي الحلقات، وطريقة لتحضيره ، وتركيبة صيدلانية تشتمل عليه
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
WO2008086014A3 (en) Bis-aryl amide derivatives useful for the treatment of cancer
HK1116161A1 (en) Substituted amide derivatives as protein kinase inhibitors
WO2007048070A3 (en) Pyrrolo-pyridine derivatives for the treatment of cancer diseases
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
MX2022015106A (es) Proceso para preparar tapinarof.
NZ749427A (en) Thiophene, manufacturing method thereof, and pharmaceutical application of same
WO2018118791A3 (en) Novel quinazolinones that inhibit the formation of tau oligomers and their method of use
PH12017501397B1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
WO2009153305A3 (en) Pharmaceutical compositions of montelukast sodium
WO2013190455A3 (en) Process for the preparation of lurasidone hydrochloride
WO2016139683A3 (en) Pharmaceutical compositions of lurasidone and process for preparing the same
MX2023009372A (es) Proceso para la preparacion de compuestos enlazantes de farmaco.
WO2017064635A3 (en) Saroglitazar magnesium, compositions containing it, process for its preparation
GB202016450D0 (en) Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
WO2018060962A3 (en) Metformin amino acid compounds and methods of using the same
WO2017093866A3 (en) An improved process for the preparation of indigo carmine
WO2017034242A3 (ko) 신규한 카테콜 유도체 및 이를 포함하는 약학적 조성물
PH12017501828A1 (en) Stabilized pharmaceutical composition and method for preparing same
WO2012038971A3 (en) Novel polymorphs of febuxostat